What to Know About Ketamine for Treatment-Resistant Depression
Summary by publicgoodnews.com
1 Articles
1 Articles
Earlier this year, the Food and Drug Administration (FDA) expanded its approval of Spravato, a ketamine-derived nasal spray originally approved to treat treatment-resistant depression (TRD) when taken alongside an oral antidepressant. This expansion means that patients with TRD can now use it as a standalone treatment when their condition doesn't improve with antidepressants. While ketamine is highly effective at relieving the symptoms of depres…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium